14 - Metastaz - Miss Fortune

(6:28)

Justin Balko on Activations in the JAK-STAT Pathway in Triple-Negative Breast Cancer

(3:18)

Phase III COMBI-d Study of Dabrafenib and Trametinib in Patients With Melanoma

(2:12)

Predicted sensitivity to ET (SET2,3 index): results of an analysis of the SWOG S8814 trial

(1:18)

Metastaz Endişesi Yaşamak Prof Dr Nil Molinas Mandel

(2:4)

Richard Goldberg, MD, talks patient response with the combination of MEK and PD-1 inhibitors

(1:31)

Dr. Stupp Discusses Results from the EF-14 Trial

(1:8)

TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis

(2:5)

Yale Cancer Center Grand Rounds | March 14, 2023

(47:23)

Managing Disease Progression in Metastatic Melanoma

(3:50)

Antibody-Drug Conjugates for HER2-Low Disease: 2023 KU Breast Cancer Year in Review

(2:6)

Maintenance pembrolizumab vs placebo for metastatic urothelial cancer

(2:57)

Tanner shares his journey receiving treatment for Stage 4 Melanoma that metastasized to his brain.

(9:39)

Data from the EP-14 Trial Evaluating Tumor Treating Fields in Brain Cancer

(54)

Dr. Nghiem on Pembrolizumab for Advanced Merkel Cell Carcinoma

(50)

Results for Tisotumab Vedotin in Patients With Metastatic or Recurrent Cervical Cancer

(1:10)

Palbociclib Shows Promise for Treatment of Brain Metastases Harboring CDK Alterations

(1:14)

Next steps for improving outcomes for patients with oligometastatic esophagogastric cancer

(50)

Richard M. Goldberg, MD, FASCO on KRAS wild type or mutant in right or left-sided mCRC patients

(42)

UT researchers find compound that could be major breast cancer breakthrough

(1:34)